Tertiary Hyperparathyroidism

Overview


Plain-Language Overview

Tertiary Hyperparathyroidism is a condition that affects the parathyroid glands, which are small glands in the neck that help regulate calcium levels in the body. It usually develops after long-standing problems with the kidneys, causing the parathyroid glands to become overactive and produce too much parathyroid hormone (PTH). This excess hormone causes the body to release too much calcium from the bones into the blood, leading to high blood calcium levels. The condition can cause symptoms like bone pain, muscle weakness, and kidney stones. It mainly affects the skeletal system and the kidneys, disrupting normal calcium balance and bone health.

Clinical Definition

Tertiary Hyperparathyroidism is characterized by autonomous and excessive secretion of parathyroid hormone (PTH) following prolonged secondary hyperparathyroidism, typically due to chronic kidney disease. The persistent stimulation of the parathyroid glands by hypocalcemia and hyperphosphatemia leads to gland hyperplasia and loss of normal feedback regulation. This results in hypercalcemia despite correction of the initial cause, distinguishing it from secondary hyperparathyroidism. The condition is clinically significant because it causes bone resorption, soft tissue calcifications, and nephrolithiasis. It often occurs in patients with end-stage renal disease who have undergone renal transplantation or remain on dialysis. Diagnosis and management are critical to prevent complications such as osteitis fibrosa cystica and vascular calcifications.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.